This study explores the effectiveness of toxin testing in predicting Clostridioides difficile infection (CDI) outcomes, revealing that patients with negative toxin results were less likely to ...

A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C. diff) guided by the principles of ...

Clostridium difficile infection is one of the most common healthcare-associated infections in adults in the United States. Older Americans are especially vulnerable to CDI, 2 and this infection has ...

A single Clostridium difficile infection presents an array of challenges for hospitals. A December 2015 study in the American Journal of Infection Control found C. difficile infections can increase ...

Please provide your email address to receive an email when new articles are posted on . Saha and colleagues conducted a prospective study of 50 patients (median age, 51 years; 66% female) with CDI at ...

Please provide your email address to receive an email when new articles are posted on . GenePOC Inc. has announced the launch and FDA clearance of its Clostridium difficile molecular test, GenePOC ...

Fecal transplants should be considered for patients with recurrent cases of Clostridium difficile whose symptoms cannot be addressed by antibiotics, the Infectious Diseases Society of America said in ...

After piloting new Clostridioides difficile guidelines for nine months, Memorial Healthcare System reduced unnecessary treatments by 20.1%, according to a study published June 27 in the American ...

After the first year of interventions at Emory Saint Joseph's Hospital, there was a 63% decrease in hospital-onset C. diff cases as compared to the two years prior. Through a series of interventions ...

Hospitals across the country are being challenged by diagnosing a contagious and deadly superbug. A local lab has a solution to the illness affecting hundreds of thousands of Americans. Clostridium ...